Cargando…
Identifying candidate agents for lung adenocarcinoma by walking the human interactome
Despite recent advances in therapeutic strategies for lung cancer, mortality is still increasing. Therefore, there is an urgent need to identify effective novel drugs. In the present study, we implement drug repositioning for lung adenocarcinoma (LUAD) by a bioinformatics method followed by experime...
Autores principales: | Sun, Yajiao, Zhang, Ranran, Jiang, Zhe, Xia, Rongyao, Zhang, Jingwen, Liu, Jing, Chen, Fuhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042291/ https://www.ncbi.nlm.nih.gov/pubmed/27729798 http://dx.doi.org/10.2147/OTT.S97357 |
Ejemplares similares
-
MiR‐148b suppressed non‐small cell lung cancer progression via inhibiting ALCAM through the NF‐κB signaling pathway
por: Jiang, Zhe, et al.
Publicado: (2019) -
Walking the interactome for candidate prioritization in exome sequencing studies of Mendelian diseases
por: Smedley, Damian, et al.
Publicado: (2014) -
Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes
por: Shi, Hongbo, et al.
Publicado: (2013) -
A Random Walk-Based Method to Identify Candidate Genes Associated With Lymphoma
por: Sheng, Minjie, et al.
Publicado: (2021) -
Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma
por: Guo, Tingting, et al.
Publicado: (2019)